Maintaining CDK4/6 inhibition constrains drug‑resistant breast tumors by delaying cell‑cycle entry, and adding CDK2 inhibition further deepens control to guide post‑progression therapy.
KeyCorp is a bank holding company, which engages in the provision of financial services. It operates through the Consumer Bank and Commercial Bank segments. The Consumer Bank segment offers deposit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback